Disease detection and resource use in the safety and control arms of the HPV FOCAL cervical cancer screening trial

British Journal of Cancer

Volumn 115, Issue 12, 2016, Pages 1487-1494

  Coldman, Andrew J ^a   Gondara, Lovedeep ^a   Smith, Laurie W ^a   Van Niekerk, Dirk ^b   Ceballos, Kathy ^b   Krajden, Mel ^c   Cook, Darrel ^a   Quinlan, David J ^d   Lee, Marette ^d   Stuart, Gavin C E ^d   Peacock, Stuart ^a   Martin, Ruth Elwood ^d   Gentile, Laura ^b   Franco, Eduardo L ^e   Ogilvie, Gina S ^d,f  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; COLPOSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; INFECTION CONTROL; LIQUID BASED CYTOLOGY; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PATIENT REFERRAL; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

ADULT; AGED; FEMALE; HUMANS; MIDDLE AGED; UTERINE CERVICAL NEOPLASMS;

EID: 84995784197     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.368     Document Type: Article

References (37)

1. Anderson GH, Boyes DA, Benedet JL, Le Riche JC, Matisic JP, Suen KC, Worth AJ, Millner A, Bennett OM (1988) Organisation and results of the cervical cytology screening programme in British Columbia, 1955-85.
2. Br Med J (Clin Res Ed) 296(6627): 975-978.
3. Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J (2012) Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine 30: F88-F99.
4. Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J (2011) Worldwide burden of cervical cancer in 2008. Ann Oncol 22(12): 2675-2686.
5. Australian Government (2014) National Cervical Screening Program Renewal. Available at http://www. cancerscreening. gov. au/internet/screening/ publishing. nsf/Content/overview-of-the-renewal (Accessed on 19 August 2014).
6. BC Cancer Agency (2014) Cervical Cancer Screening Program 2013 Annual Report.
7. Boyes DA, Morrison B, Knox EG, Draper GJ, Miller AB (1982) A cohort study of cervical cancer screening in British Columbia. Clin Invest Med 5(1): 1-29.
8. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume 1-The analysis of case-control studies. IARC Scientific Publications: Lyon, France. Canadian Cancer Society's Advisory Committee on Cancer Statistics (2013) Canadian Cancer Statistics 2013.
9. Coldman AJ, Phillips N, van Niekerk DJ, Smith LW, Krajden M, Cook DA, Quinlan DJ, Ehlen TG, Miller D, Stuart GC, Peacock SJ, Martin RE, Franco EL, Ogilvie GS (2015) Projected impact of HPV and LBC primary testing on rates of referral for colposcopy in a Canadian cervical cancer screening program. J Obstet Gynaecol Can 37(5): 412-420.
10. Cook DA, Mei W, Smith LW, van Niekerk DJ, Ceballos K, Franco EL, Coldman AJ, Ogilvie GS, Krajden M (2015) Comparison of the Roche cobas 4800 and Digene Hybrid Capture 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial. BMC Cancer 15(1): 968.
11. Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ (2008) Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26(Suppl 10): K29-K41.
12. Cuzick J, Clavel C, Petry KU, Meijer CJ, Hoyer H, Ratnam S, Szarewski A, Birembaut P, Kulasingam S, Sasieni P, Iftner T (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119(5): 1095-1101.
13. DeMets DL, Lan KKG (1995) Recent Advances in Clinical Trial Design and Analysis. In Thall PF (ed). Kluwer Academic Publishers: Massachusetts, USA.
14. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T. Joint European Cohort, S. (2008) Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 337: A1754.
15. Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, Peto J, Ronco G, Sasieni P, Wheeler CM (2011) Eurogin 2010 roadmap on cervical cancer prevention. Int J Cancer 128(12): 2765-2774.
16. Health Council of the Netherlands (2011) Population Screening for Cervical Cancer. Available at http://www. gezondheidsraad. nl/sites/default/files/ Summary-Population-screening-cervical-cancer. pdf (Accessed on 21 December 2013).
17. Kitchener HC, Almonte M, Thomson C, Wheeler P, Sargent A, Stoykova B, Gilham C, Baysson H, Roberts C, Dowie R, Desai M, Mather J, Bailey A, Turner A, Moss S, Peto J (2009) HPV testing in combination with liquidbased cytology in primary cervical screening (ARTISTIC): A randomised controlled trial. Lancet Oncol 10(7): 672-682.
18. Leinonen MK, Nieminen P, Lonnberg S, Malila N, Hakama M, Pokhrel A, Laurila P, Tarkkanen J, Anttila A (2012) Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland. BMJ 345: e7789.
19. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlee F, Franco EL. Canadian cervical cancer screening trial study, group (2007) Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer. N Engl J Med 357(16): 1579-1588.
20. Morrison BJ, Coldman AJ, Boyes DA, Anderson GH (1996) Forty years of repeated screening: the significance of carcinoma in situ. Br J Cancer 74(5): 814-819.
21. Moyer VA. on behalf of the US Preventive Services Task Force (2012) Screening for cervical cancer: US preventive services task force recommendation statement. Ann Intern Med 156(12): 880-891.
22. Murphy J, Kennedy E, Dunn S, Fung Kee Fung M, Gzik D, McLachlin CM, Shier M, Paszat L (2011) Cervical Screening: Guideline Recommendations. Available at https://www. cancercare. on. ca/common/pages/ UserFile. aspx?fileId=124511 (Accessed on: 19 December 2013).
23. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, Matchar DB (2000) Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 132(10): 810-819.
24. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, Radberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J (2007) Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357(16): 1589-1597.
25. Ogilvie GS, Krajden M, van Niekerk DJ, Martin RE, Ehlen TG, Ceballos K, Smith LW, Kan L, Cook DA, Peacock S, Stuart GC, Franco EL, Coldman AJ (2012) Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial-the HPV FOCAL Study. Br J Cancer 107(12): 1917-1924.
26. Ogilvie GS, van Niekerk DJ, Krajden M, Martin RE, Ehlen TG, Ceballos K, Peacock SJ, Smith LW, Kan L, Cook DA, Mei W, Stuart GC, Franco EL, Coldman AJ (2010) A randomized controlled trial of human papillomavirus (HPV) testing for cervical cancer screening: trial design and preliminary results (HPV FOCAL Trial). BMC Cancer 10: 111.
27. Rijkaart DC, Berkhof J, Rozendaal L, van Kemenade FJ, Bulkmans NW, Heideman DA, Kenter GG, Cuzick J, Snijders PJ, Meijer CJ (2012) Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 13(1): 78-88.
28. Rijkaart DC, Berkhof J, van Kemenade FJ, Coupe VM, Hesselink AT, Rozendaal L, Heideman DA, Verheijen RH, Bulk S, Verweij WM, Snijders PJ, Meijer CJ (2012) Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening. Int J Cancer 130(3): 602-610.
29. Ronco G, Dillner J, Elfström KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P (2014) Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383(9916): 524-532.
30. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: A randomised controlled trial. Lancet Oncol 11(3): 249-257.
31. Ronco G, Meijer CJ, Cuzick J, Giorgi-Rossi P, Peto J, Segnan N, Dillner J (2012) Screening for cervical cancer. Ann Internal Med 156(8): 604-605.
32. Sasieni P, Cuzick J (2002) Could HPV testing become the sole primary cervical screening test? J Med Screen 9(2): 49-51.
33. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, Wentzensen N, Downs Jr LS, Spitzer M, Moscicki AB, Franco EL, Stoler MH, Schiffman M, Castle PE, Myers ER, Chelmow D, Herzig A, Kim JJ, Kinney W, Herschel WL, Waldman J (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis 16(3): 175-204.
34. van den Akker-vanMarie ME, van Ballegooijen M, Rozendaal L, Meijer C. J. L. M. , Habbema JD (2003) Extended duration of the detectable stage by adding HPV test in cervical cancer screening. Br J Cancer 89: 1830-1833.
35. Wentzensen N, Schiffman M, Palmer T, Arbyn M (2016) Triage of HPV positive women in cervical cancer screening. J Clin Virol 76: S49-S55.
36. Wright TC, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL (2012) The ATHENA human papillomavirus study: design, methods, and baseline results. Am J Obstet Gynecol 206: 46.
37. Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL (2015) Primary cervical cancer screening with human pappillomavirus: End of study results from the Athena study using HPV as the first-line screening test. Gynecol Oncol 136: 189-197.